Wuppertal, Germany

Michael Gerisch

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 10.5

ph-index = 3

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2003-2020

Loading Chart...
Loading Chart...
10 patents (USPTO):

Title: Michael Gerisch - Innovator in Pharmaceutical Patents

Introduction

Michael Gerisch, an accomplished inventor based in Wuppertal, Germany, has made significant contributions to the field of pharmaceuticals through his ten innovative patents. His expertise primarily focuses on developing novel compounds that address critical health issues, particularly in the realm of cardiovascular and renal diseases, as well as disorders related to phosphatidylinositol-3-kinase (PI3K) activity.

Latest Patents

Among Michael Gerisch's latest inventions is the patent for 2-amino-N-[7-methoxy-2, 3-dihydroimidazo-[1,2-c] quinazolin-5-yl] pyrimidine-5-carboxamides. This innovation pertains to a new class of 2,3-dihydroimidazo[1,2-c]quinazoline compounds, which are formulated into pharmaceutical compositions for the inhibition of PI3K. This advancement presents the potential for treating hyper-proliferative and angiogenesis disorders, either as a standalone treatment or in synergy with other active agents.

Another recent patent features hydroxyalkyl-substituted phenyltriazole derivatives. This invention relates to 5-(hydroxyalkyl)-1-phenyl-1,2,4-triazole derivatives and their applications in preventing and treating diseases, especially in cardiovascular and renal health.

Career Highlights

Michael Gerisch has enhanced his skills and knowledge through his tenure at reputable organizations, notably Bayer Pharma Aktiengesellschaft and Bayer Intellectual Property GmbH. His experience in these companies allowed him to hone his inventive capabilities, contributing to advancements in pharmaceutical research and development.

Collaborations

Throughout his career, Michael has collaborated with esteemed colleagues, including Susanne Röhrig and Ulrich Rester. These partnerships have fostered an environment of innovation and shared expertise, leading to the successful development of several impactful products and patents.

Conclusion

In summary, Michael Gerisch stands as a notable figure in the sphere of pharmaceutical innovation, with a solid portfolio of patents that aim to tackle pressing health challenges. His ongoing dedication to research and collaboration not only highlights his role as a pioneer in the field but also promises to contribute significantly to medical science in the years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…